KALRAY/EASYMILE
6.1.2021 18:02:21 CET | Business Wire | Press release
Autonomous technology provider EasyMile and intelligent processors supplier Kalray have deepened their relationship with the signature of a Memorandum of Understanding (MoU) formalizing their relationship to develop intelligent systems.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210106005553/en/
The partnership follows their work together in the ten-partner-strong ES3CAP collaborative project, led by Kalray and announced in 2019. The ES3CAP program, with a budget of €22.2 million over 3 years, aims to build a hardware and software platform intended for manufacturers developing critical applications requiring high computing capacity in the fields of aeronautics (aviation, flying cabs, UAVs), defense and, autonomous vehicles.
EasyMile’s technology interacts with all kinds of next-generation radars, cameras, and lidar sensors to autonomize a range of vehicles. Its vehicle-agnostic software makes it the partner of choice for global Original Equipment Manufacturers (OEMs). As a fabless company, EasyMile develops autonomous vehicle solutions that tackle identified use-cases very precisely using common-core, unique technology. EasyMile’s solutions require underlying platforms providing both safety and performance.
Benoit Perrin, Managing Director of EasyMile : “Safety and performance reliability are key to embedded systems. This collaboration with Kalray, which started with the ES3CAP program, matches the high criteria we expect of our partners and we are delighted to be working with them .”
Eric Baissus, CEO of Kalray : ”EasyMile is one of the most advanced companies delivering safe solutions for autonomous vehicles. For us, this collaboration is further evidence of the value that our MPPA® intelligent processors and SuperECU® solution can bring to easily build safe autonomous systems .”
Autonomous vehicles require ECUs (“Electronic Computing Unit”) capable of running a multitude of applications in parallel with no compromise on safety. Kalray’s SuperECU®, based on Kalray MPPA® Intelligent Processor, is a patented platform capable of providing both the demanding performance required to compute functions such as artificial intelligence algorithms but also to support multi-applications with different levels of criticality on the same chip. Kalray’s MPPA® processor is one of the rare solutions on the market to ensure complete freedom from interference between these applications, which is a key attribute in building safe systems.
In addition, Kalray intelligent processors are not only capable of executing AI algorithms but can also simultaneously execute a wide set of different processing such as mathematical algorithms, signal processing and networking software stacks. This heterogenous multi-processing capability is also a critical requirement for autonomous vehicles, and is a unique capability of Coolidge™, 3rd generation of MPPA® processor available now.
ABOUT EASYMILE
EasyMile provides software and complete solutions for driverless mobility and goods transportation. EasyMile partners with manufacturers to autonomize their vehicles with award-winning technology built on safety-by-design, ready for deployment today.
Since 2014, Easymile has become known for quality delivery and real-world deployments. Its proven technology has driven autonomous vehicles in 300+ locations in more than 30 countries: The EZ10 is the most deployed autonomous shuttle in the world. For material handling, TractEasy is a tow-truck solution optimizing supply chains with cross/indoor-outdoor, 24/7 material handling at factories and industrial sites.
With several mass operations around the world EasyMile was the first to deploy fully driverless at Level 4 of autonomous driving. It was also the first autonomous vehicle solutions provider to be ISO 9001 certified. At the core of EasyMile's cutting-edge sofware is a step-by-step approach to safety proven by a zero-collision record. EasyMile's future-ready technology specializes in robotics, computer vision and vehicle dynamics powered by deep learning. Among its customers leading transport operators, city authorities, airports, business parks, manufatcurers, factories, logistics centers and universities.
Headquartered in Toulouse, France, the company employs close to 250 highly qualified employees. In addition to the two founders, Gilbert Gagnaire and Philippe Ligier, EasyMile has investors who are also technical partners: Alstom, Continental and Bpifrance. www.easymile.com
ABOUT KALRAY
Kalray (Euronext Growth Paris - FR0010722819 - ALKAL) is a fabless semiconductor company, leading provider in a new generation of processors specialized in Intelligent Data Processing from Cloud to Edge. Kalray MPPA® Intelligent Processors are able to capture and analyze on the fly massive data flows, and interact in real time with the outside world. These processors are capable of running demanding AI algorithms and simultaneously a wide set of different processing and control tasks such as intensive mathematical algorithms, signal processing, network or storage software stacks. Kalray’s Intelligent Processors can be deployed in fast-growing sectors from Cloud to Edge: modern data centers, 5G telecom networks, autonomous vehicles, healthcare equipment, industry 4.0, drones and robots… Kalray’s offering includes processors, acceleration cards and a software suite, for a broad spectrum of customers such as next generation data center equipment manufacturers and service providers, system integrators and consumer product manufacturers such as car makers. Founded in 2008 as a spin-off of CEA French lab, Kalray counts among its investors: Alliance Venture (Renault-Nissan-Mitsubishi), Safran, NXP Semiconductors, CEA and Bpifrance. Read more at: www.kalrayinc.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20210106005553/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces Positive CHMP Opinion for Opzelura® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 13:30:00 CEST | Press release
If approved, Opzelura® (ruxolitinib) cream will be the first steroid-free, topical JAK treatment option in the European Union (EU) for adults with moderate atopic dermatitis (AD) for whom standard topical therapies have failedAD, the most common type of eczema which affects 230 million people globally,1 is a chronic, recurring, inflammatory and highly pruritic (itchy) skin condition that can have a significant impact on daily life2Phase 3 TRuE‑AD4 data supporting the positive CHMP opinion demonstrated that ruxolitinib cream met both co‑primary endpoints at Week 8, maintained disease control with as-needed treatment through Week 24 and was well tolerated3,4,5 Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids
Datroway® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 13:00:00 CEST | Press release
Recommendation based on TROPION-Breast02 phase 3 trial where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival If approved, Datroway has potential to be the first TROP2 directed antibody drug conjugate for patients in EU with a demonstrated overall survival benefit as first-line treatment Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use
DAYBU®(trofinetide) Recommended for Approval in the European Union by CHMP26.6.2026 12:49:00 CEST | Press release
-- European Commission decision expected in the coming months-- If approved, DAYBU®would become the first treatment for neurobehavioral symptoms of Rett syndrome in the European Union Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion following a re-examination procedure, recommending the granting of a marketing authorization for DAYBU® (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older. If granted marketing authorization by the European Commission, DAYBU® would be the first therapy approved for this indication in the European Union (EU). “The CHMP’s positive opinion for DAYBU® is an important milestone in our mission to bring this innovative therapy to the EU, where there are no therapies specifically approved for the neurobehavioral symptoms of this devastating
HTEC Showcases Lakebase Branching at Databricks’ Data & AI Summit26.6.2026 11:18:00 CEST | Press release
HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. The Solution was developed in collaboration with a leading risk and compliance technology provider who serves financial institutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260626875859/en/ HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. Solving Critical Development Bottlenecks in Regulated Environments At the core of the collaboration was a shared challenge: how to enable modern data workflows in an envi
Stallergenes Greer Named One of Switzerland’s Best Managed Companies for 202626.6.2026 10:28:00 CEST | Press release
Stallergenes Greer, a global leader in allergy care, has been recognised for its overall business performance, company culture, and sustained growth by receiving the prestigious 2026 Switzerland’s Best Managed Companies award. The 2026 Best Managed Companies programme award winners are among Switzerland’s best private companies. The awards are derived from Deloitte’s global Best Managed Companies awards programme, an internationally recognised programme that evaluates businesses based on their leadership in the areas of strategy, culture and commitment, capabilities, innovation, governance and financial performance. Applicants are evaluated by an independent jury of experts. The evaluation of the Switzerland awards is based on more than 30 years of observed practice from the global awards programme that has been rolled out in 50+ countries worldwide. This recognition reflects Stallergenes Greer's consistent ability to deliver on its strategic vision while maintaining the operational di
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom